https://na.geneseeq.com/biomarker-ici-therapy/ 2020-05-17T00:44:36+00:00 https://na.geneseeq.com/geneseeq-asco-2019/ 2020-05-27T18:29:10+00:00 https://na.geneseeq.com/geneseeq-and-illumina/ 2020-05-28T02:35:43+00:00 https://na.geneseeq.com/my-tech-travel-setup/ 2020-07-22T16:33:46+00:00 https://na.geneseeq.com/wp-content/uploads/2018/10/Logo2-no-bg.png https://na.geneseeq.com/geneseeq-to-showcase-novel-translational-research-at-the-2020-aacr-virtual-annual-meeting-ii/ 2021-01-25T14:41:02+00:00 https://na.geneseeq.com/geneseeq-and-collaborators-to-share-new-clinical-research-data-during-the-asco20-virtual-scientific-program/ 2021-01-25T14:41:46+00:00 https://na.geneseeq.com/iaslc-wclc2020-news/ 2021-01-26T16:46:41+00:00 https://na.geneseeq.com/geneseeq-collaborates-with-illumina-to-develop-and-commercialize-comprehensive-cancer-in-vitro-diagnostic-ngs-kit/ 2021-03-16T14:41:04+00:00 https://na.geneseeq.com/lung-cancer-genomic-study-reveals-timing-and-origins-of-local-and-distant-metastases-and-highlights-the-importance-of-early-cancer-detection/ 2021-03-19T17:04:56+00:00 https://na.geneseeq.com/genomic-study-uncovers-new-biomarkers-for-the-efficacy-of-immunotherapy-in-nasopharyngeal-carcinoma-npc-patients/ 2021-03-25T14:46:24+00:00 https://na.geneseeq.com/geneseeq-to-present-at-american-association-for-cancer-research-annual-meeting-2021/ 2021-04-09T13:05:17+00:00 https://na.geneseeq.com/geneseeq-and-astrazeneca-collaborate-to-build-guangzhou-bio-diagnostics-innovation-center/ 2021-04-27T14:03:03+00:00 https://na.geneseeq.com/geneseeq-study-shows-ctdna-evaluation-in-early-postoperative-phase-predicts-risk-of-recurrence-in-colorectal-cancer/ 2021-05-19T20:31:50+00:00 https://na.geneseeq.com/geneseeq-presenting-data-at-the-american-society-of-clinical-oncology-annual-meeting-2021/ 2021-05-27T19:12:59+00:00 https://na.geneseeq.com/geneseeq-joins-integrated-dna-technologies-idt-align-program/ 2021-06-17T17:41:34+00:00 https://na.geneseeq.com/geneseeq-works-with-hutchmed-and-astrazeneca-in-met-inhibitor-approval-for-lung-cancer-patients-in-china/ 2021-08-24T15:52:55+00:00 https://na.geneseeq.com/geneseeq-study-evaluates-ctdna-mrd-to-predict-response-to-therapy-and-assess-prognosis-in-locally-advanced-rectal-cancer/ 2021-08-31T17:55:53+00:00 https://na.geneseeq.com/geneseeq-presents-ctdna-early-lung-cancer-detection-data-at-wclc/ 2021-09-08T13:36:29+00:00 https://na.geneseeq.com/geneseeq-presents-10-studies-on-mrd-early-cancer-detection-cancer-diagnosis-and-cancer-biology-research-at-emso-2021/ 2021-09-15T15:27:04+00:00 https://na.geneseeq.com/geneseeq-and-zai-lab-announce-strategic-collaboration-to-advance-cancer-drug-rd/ 2021-10-14T02:58:17+00:00 https://na.geneseeq.com/geneseeq-study-shows-high-performance-results-in-colorectal-cancer-early-detection/ 2021-10-28T20:52:15+00:00 https://na.geneseeq.com/geneseeq-collaborates-on-research-identifying-predictive-biomarkers-for-guiding-personalized-adjuvant-treatment-in-resected-egfr-positive-non-small-cell-lung-cancer/ 2021-11-08T19:17:31+00:00 https://na.geneseeq.com/geneseeq-forms-lung-cancer-strategic-partnerships-with-takeda-and-astrazeneca-in-on-the-same-day/ 2021-11-11T18:16:44+00:00 https://na.geneseeq.com/geneseeq-announces-new-publication-utilizing-ultradeep-sequencing-technology-automated-ttriple-groom-sequencing-atg-seqtm-to-monitor-minimal-residual-disease-in-postoperative-non-small-cell-lung-can/ 2021-11-22T15:29:49+00:00 https://na.geneseeq.com/geneseeqs-cancer-early-detection-study-series-decipher-yield-another-publication-in-hepatology-to-explore-the-performance-of-cfdna-fragmentomics-in-liver-cancer/ 2022-01-04T13:15:38+00:00 https://na.geneseeq.com/geneseeq-presents-9-posters-at-aacr-2022/ 2022-04-05T13:23:56+00:00 https://na.geneseeq.com/geneseeq-collaborates-on-another-minimal-residual-disease-study-in-chemoradiotherapy-treated-inoperable-localized-non-small-cell-lung-cancer-patients/ 2022-05-19T16:36:15+00:00 https://na.geneseeq.com/geneseeq-at-asco-2022/ 2022-05-31T19:07:04+00:00 https://na.geneseeq.com/geneseeq-multicancer-early-detection-study-yields-promising-results/ 2022-06-13T14:42:45+00:00 https://na.geneseeq.com/geneseeq-and-collaborators-publish-new-findings-from-decipher-series-exploring-single-cfdna-feature-based-machine-learning-model-for-lung-cancer-early-detection/ 2022-07-05T16:37:04+00:00 https://na.geneseeq.com/geneseeq-brazilian-hospital-partner-on-co-establishment-of-in-house-ngs-lab/ 2022-07-19T17:56:01+00:00 https://na.geneseeq.com/geneseeq-and-collaborators-to-share-new-findings-at-world-conference-on-lung-cancer-2022/ 2022-08-03T15:55:49+00:00 https://na.geneseeq.com/geneseeq-to-present-five-posters-at-european-society-for-medical-oncology-2022/ 2022-09-07T16:54:54+00:00 https://na.geneseeq.com/interesting-findings-on-ctdna-based-mrd-detection-in-patients-with-resectable-non-small-cell-lung-cancer-by-geneseeq/ 2022-10-12T19:06:12+00:00 https://na.geneseeq.com/geneseeq-study-highlights-ctdna-monitoring-clinical-value-in-colorectal-cancer-patients-resistant-to-braf-egfr-targeted-therapy/ 2022-10-18T14:49:50+00:00 https://na.geneseeq.com/geneseeq-study-evaluates-the-clinical-value-of-cell-free-dna-5-end-motif-profile-in-the-prediction-of-pathological-complete-response-for-larc-patients-after-neoadjuvant-chemoradiotherapy/ 2022-11-03T17:14:27+00:00 https://na.geneseeq.com/geneseeq-publishes-promising-early-lung-cancer-detection-results-in-ajrccm/ 2022-11-15T18:47:49+00:00 https://na.geneseeq.com/geneseeq-to-present-13-posters-at-aacr-2023/ 2023-04-11T14:58:57+00:00 https://na.geneseeq.com/geneseeq-to-share-eight-collaborated-studies-at-wclc-2023/ 2023-08-29T14:53:22+00:00 https://na.geneseeq.com/geneseeq-receives-chinese-nmpa-approval-for-lung-cancer-tumor-mutational-burden-ngs-test-kit/ 2023-10-13T14:00:47+00:00 https://na.geneseeq.com/fda-grants-breakthrough-designation-for-geneseeqs-multi-cancer-early-detection-solution/ 2024-01-03T15:16:43+00:00 https://na.geneseeq.com/wp-content/uploads/2024/01/CanScan-Logo-2000-461-c.png https://na.geneseeq.com/geneseeq-partners-with-jiangsu-vcare-pharmatech-to-develop-a-cdx-for-ntrk-inhibitor-in-china/ 2024-07-03T14:26:49+00:00 https://na.geneseeq.com/geneseeqs-ngs-liquid-biopsy-kit-marks-the-first-to-enter-nmpas-special-review-and-approval-of-innovative-medical-device/ 2025-01-10T21:29:01+00:00 https://na.geneseeq.com/geneseeq-unveils-groundbreaking-blood-test-for-early-detection-of-pancreatic-cancer/ 2025-05-07T14:00:58+00:00 https://na.geneseeq.com/geneseeq-showcases-cutting-edge-liquid-biopsy-research-across-multiple-cancer-types-at-asco-2025/ 2025-05-26T20:38:53+00:00 https://na.geneseeq.com/geneseeq-technology-inc-to-showcase-seventeen-studies-at-2025-american-association-for-cancer-research-aacr-annual-meeting/ 2025-05-28T19:23:50+00:00 https://na.geneseeq.com/geneseeq-at-asco-2024/ 2025-05-28T19:24:48+00:00 https://na.geneseeq.com/geneseeq-to-showcase-twelve-studies-at-2024-american-association-for-cancer-research-aacr-annual-meeting/ 2025-05-28T19:24:58+00:00 https://na.geneseeq.com/geneseeq-to-present-four-studies-at-esmo-2023/ 2025-05-28T19:25:16+00:00 https://na.geneseeq.com/wp-content/uploads/2023/10/ESMO-webnews.png https://na.geneseeq.com/geneseeq-to-showcase-new-findings-at-asco-2023/ 2025-05-28T19:25:30+00:00 https://na.geneseeq.com/geneseeq-published-new-research-on-the-clinical-use-of-circulating-free-dna-fragmentomic-in-monitoring-minimal-residual-disease-for-patients-with-non-small-cell-lung-cancer/ 2025-05-28T19:25:38+00:00 https://na.geneseeq.com/geneseeq-co-publish-with-uhn-on-using-ctdna-as-a-prognostic-biomarker-for-immunotherapy/ 2025-05-28T19:25:44+00:00 https://na.geneseeq.com/geneseeq-and-collaborators-initiate-motion-study-to-evaluate-the-performance-of-minimal-residual-disease-test-shielding-in-early-stage-lung-cancer/ 2025-05-28T19:25:51+00:00 https://na.geneseeq.com/geneseeqs-breakthrough-cancer-detection-blood-test-published-in-nature-medicine/ 2025-05-28T19:26:09+00:00 https://na.geneseeq.com/geneseeqprime-gains-fda-510k-clearance/ 2025-09-02T14:00:42+00:00 https://na.geneseeq.com/geneseeq-validates-cell-free-dna-blood-test-for-early-detection-of-pancreatic-cancer-in-a-prospective-study/ 2025-09-29T15:12:21+00:00 https://na.geneseeq.com/geneseeq-receives-nmpa-approval-for-pantrkare-chinas-first-ngs-based-pan-solid-tumor-companion-diagnostic-kit-for-ntrk-gene-fusions/ 2025-11-10T15:00:31+00:00 https://na.geneseeq.com/geneseeq-gains-ce-marks-for-ngs-based-test-kits-for-solid-tumors-and-hematological-cancer/ 2025-11-20T18:27:09+00:00 https://na.geneseeq.com/geneseeq-receives-ce-marks-for-mrd-and-mced-tests/ 2025-11-20T18:29:24+00:00 https://na.geneseeq.com/geneseeq-canada-named-first-genomic-testing-partner-in-uhns-sherlock-study/ 2026-07-14T14:05:35+00:00 https://na.geneseeq.com/pantrkare-cdx-velmarto-eratrectinib/ 2026-08-11T19:27:57+00:00 https://na.geneseeq.com/wp-content/uploads/2026/08/pantrkare-ntrk-gene-fusion-detection-kit-scaled.jpg